Page last updated: 2024-10-27

gemfibrozil and Nephrotic Syndrome

gemfibrozil has been researched along with Nephrotic Syndrome in 3 studies

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research Excerpts

ExcerptRelevanceReference
"Gemfibrozil treatment produced a marked reduction in plasma triglyceride (51%, P = 0."6.66Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. ( Cheung, AK; Ellis-Benigni, K; Groggel, GC; Wilson, DE, 1989)
"Gemfibrozil treatment produced a marked reduction in plasma triglyceride (51%, P = 0."2.66Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. ( Cheung, AK; Ellis-Benigni, K; Groggel, GC; Wilson, DE, 1989)
"Nephrotic syndrome is the collective name given to a group of symptoms that include proteinuria, lipiduria, hypoalbuminaemia, oedema, hypercholesterolaemia, elevated triglycerides, and hyperlipidaemia."2.49Lipid-lowering agents for nephrotic syndrome. ( Fan, J; Jiang, L; Kong, X; Li, Z; Wu, T; Yuan, H, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kong, X1
Yuan, H1
Fan, J1
Li, Z1
Wu, T1
Jiang, L1
D'Amico, G1
Gentile, MG1
Groggel, GC1
Cheung, AK1
Ellis-Benigni, K1
Wilson, DE1

Reviews

1 review available for gemfibrozil and Nephrotic Syndrome

ArticleYear
Lipid-lowering agents for nephrotic syndrome.
    The Cochrane database of systematic reviews, 2013, Dec-10, Issue:12

    Topics: Adult; Child; Fatty Acids, Monounsaturated; Fluvastatin; Gemfibrozil; Humans; Hydroxymethylglutaryl-

2013

Trials

2 trials available for gemfibrozil and Nephrotic Syndrome

ArticleYear
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
    Kidney international. Supplement, 1991, Volume: 31

    Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lo

1991
Treatment of nephrotic hyperlipoproteinemia with gemfibrozil.
    Kidney international, 1989, Volume: 36, Issue:2

    Topics: Adult; Aged; Apolipoproteins; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creat

1989